Literature DB >> 9247673

A semiautomated alanine:glyoxylate aminotransferase assay for the tissue diagnosis of primary hyperoxaluria type 1.

G Rumsby1, T Weir, C T Samuell.   

Abstract

We have developed a sensitive assay for the measurement of alanine:glyoxylate aminotransferase (EC 2.6.1.44) activity in human liver. The assay is partly automated, and takes into consideration the sensitivity of the reaction to pH and to glyoxylate concentration. It is less subject to interference from other enzymes utilizing glyoxylate and to chemical interference from glyoxylate itself and can therefore be used without correction for cross-over by glutamate:glyoxylate aminotranferase (EC 2.6.1.4). The assay allows clear discrimination between normal and affected livers and is sufficiently sensitive to measure enzyme activity in fetal liver samples. Enzyme activity ranged from 17.9 to 38.5 mumol/h/mg protein in control livers (n = 9) and 0.8 to 9.5 mumol/h/mg protein in 30 of 39 hyperoxaluric patients studied. Normal alanine:glyoxylate aminotransferase activity (from 22.8 to 45.5 mumol/h/mg protein) allowed exclusion of primary hyperoxaluria type 1 in the other nine hyperoxaluric patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247673     DOI: 10.1177/000456329703400411

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  10 in total

1.  Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer.

Authors:  Eduardo C Salido; Xiao M Li; Yang Lu; Xia Wang; Alfredo Santana; Namita Roy-Chowdhury; Armando Torres; Larry J Shapiro; Jayanta Roy-Chowdhury
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-16       Impact factor: 11.205

Review 2.  Primary hyperoxaluria type 1: is genotyping clinically helpful?

Authors:  Ernst Leumann; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2005-03-17       Impact factor: 3.714

3.  Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.

Authors:  Joseph T Behnam; Emma L Williams; Susanne Brink; Gill Rumsby; Christopher J Danpure
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

4.  Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.

Authors:  Sonia Fargue; John Knight; Ross P Holmes; Gill Rumsby; Christopher J Danpure
Journal:  Biochim Biophys Acta       Date:  2016-02-06

5.  Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.

Authors:  Sonia Fargue; Jackie Lewin; Gill Rumsby; Christopher J Danpure
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

6.  In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase.

Authors:  Erin D Hopper; Adrianne M C Pittman; Michael C Fitzgerald; Chandra L Tucker
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

7.  Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.

Authors:  A Santana; E Salido; A Torres; L J Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

8.  Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria.

Authors:  Oliver Clifford-Mobley; Gill Rumsby; Swati Kanodia; Mohammed Didi; Richard Holt; Senthil Senniappan
Journal:  Pediatr Nephrol       Date:  2017-07-27       Impact factor: 3.714

9.  The role of protein denaturation energetics and molecular chaperones in the aggregation and mistargeting of mutants causing primary hyperoxaluria type I.

Authors:  Noel Mesa-Torres; Israel Fabelo-Rosa; Debora Riverol; Cristina Yunta; Armando Albert; Eduardo Salido; Angel L Pey
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

10.  Mutational analysis of AGXT in two Chinese families with primary hyperoxaluria type 1.

Authors:  Guo-min Li; Hong Xu; Qian Shen; Yi-nv Gong; Xiao-yan Fang; Li Sun; Hai-mei Liu; Yu An
Journal:  BMC Nephrol       Date:  2014-06-17       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.